Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Rabe

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Archives of Gynecology and Obstetrics|November 23, 2016
Symptoms of uterine myomas: data of an epidemiological study in GermanyDolores Foth, Friedrich-Wilhelm Röhl, Cornelia Friedrich, et al.
Journal of the American Society of Nephrology : JASN|January 30, 2004
Beneficial Effects of Estrogens on Indices of Renal Damage in Uninephrectomized SHRsp RatsMarie-Luise Gross, Marcin Adamczak, Thomas Rabe, et al.
Archives of Gynecology and Obstetrics|November 4, 2015
Prevalence of uterine myomas in women in Germany: data of an epidemiological studyHans-Joachim Ahrendt, Heike Tylkoski, Thomas Rabe, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 29, 2010
[S2k-guideline for therapy of acne]Alexander Nast, Christiane Bayerl, Claudia Borelli, et al.
The Journal of Family Planning and Reproductive Health Care|April 16, 2013
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolismJohannes Bitzer, Jean-Jacques Amy, Rob Beerthuizen, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|April 13, 2013
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolismJohannes Bitzer, Jean-Jacques Amy, Rob Beerthuizen, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Archives of Gynecology and Obstetrics|November 23, 2016
Symptoms of uterine myomas: data of an epidemiological study in GermanyDolores Foth, Friedrich-Wilhelm Röhl, Cornelia Friedrich, et al.
Journal of the American Society of Nephrology : JASN|January 30, 2004
Beneficial Effects of Estrogens on Indices of Renal Damage in Uninephrectomized SHRsp RatsMarie-Luise Gross, Marcin Adamczak, Thomas Rabe, et al.
Archives of Gynecology and Obstetrics|November 4, 2015
Prevalence of uterine myomas in women in Germany: data of an epidemiological studyHans-Joachim Ahrendt, Heike Tylkoski, Thomas Rabe, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 29, 2010
[S2k-guideline for therapy of acne]Alexander Nast, Christiane Bayerl, Claudia Borelli, et al.
The Journal of Family Planning and Reproductive Health Care|April 16, 2013
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolismJohannes Bitzer, Jean-Jacques Amy, Rob Beerthuizen, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|April 13, 2013
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolismJohannes Bitzer, Jean-Jacques Amy, Rob Beerthuizen, et al.
Pageof 3